As a powerful transcription factor, AR has not only been shown to play a central role in prostate cancer,[2] but also has been demonstrated to be a plausible therapeutic target for specific breast cancer subtype[31] and hepatocellular carcinoma (HCC). The gene discussed is AR; the disease is hepatocellular carcinoma.